Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 12, 2019 | Evenity finally wins EU approval; US-China biologics CDMO raises $60M | → Amgen and partner UCB have managed to convince the EMA to finally approve their bone-building drug, Evenity, to treat osteoporosis. The drug, which was originally slapped with a negative recommendation by the EU regu... |
Reviews 0
FAQ about JOINN Biologics US Inc.
When was JOINN Biologics US Inc. founded?
JOINN Biologics US Inc. was founded in 2018.
How much funding has JOINN Biologics US Inc. raised?
JOINN Biologics US Inc. has raised $150M in total across 1 funding round.
What has the press written about JOINN Biologics US Inc.?
Parsers VC has collected 2 articles mentioning JOINN Biologics US Inc., among them “Evenity finally wins EU approval; US-China biologics CDMO raises $60M” (Dec 12, 2019).
Is JOINN Biologics US Inc. still active?
Yes, JOINN Biologics US Inc. is active; its latest activity on Parsers VC dates from Jun 21, 2023.